|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash | ||||||||||||||
| Prepaid expenses | ||||||||||||||
| Total current assets | ||||||||||||||
| Cash and Investments held in Trust Account | ||||||||||||||
| Total Assets | ||||||||||||||
| Liabilities and Shareholders’ Deficit: | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | ||||||||||||||
| Accrued expenses | ||||||||||||||
| Convertible note - related parties | ||||||||||||||
| Other liabilities | ||||||||||||||
| Excise tax payable | ||||||||||||||
| Corporate tax payable | ||||||||||||||
| Income tax payable | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Overfunding loans | ||||||||||||||
| Overfunding loans | ||||||||||||||
| Derivative warrant liabilities | ||||||||||||||
| Deferred underwriting commissions | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Class A common stock, $0.0001 par value; 35,000,000 shares authorized; 2,325,987 and 2,338,586 shares subject to possible redemption at approximately $11.70 and $10.90 per share as of December 31, 2025 and 2024, respectively | ||||||||||||||
| Common Class A | ||||||||||||||
| Total class A common stock, $0.0001 par value; 35,000,000 shares authorized; 2,325,987 and 2,338,586 shares subject to possible redemption at approximately $11.70 and $10.90 per share as of December 31, 2025 and 2024, respectively | ||||||||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2025 and 2024 | ||||||||||||||
| Common stock, value | ||||||||||||||
| Common Class A | ||||||||||||||
| Common Class B | ||||||||||||||
| Common Stock Class B | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total shareholders’ deficit | ||||||||||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption and Shareholders’ Deficit | ||||||||||||||
Loading...